Home › Funds › PATHWAY WEALTH MANAGEMENT LLC › VRTX

PATHWAY WEALTH MANAGEMENT LLC position in VRTX

VERTEX PHARMACEUTICALS INC · Health Care

PATHWAY WEALTH MANAGEMENT LLC reported holding 425 shares of VRTX (VERTEX PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$222K, representing 0.15% of its reported portfolio and ranking #30 among its reported holdings. PATHWAY WEALTH MANAGEMENT LLC has disclosed VRTX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)425 sh
Reported value held$222.19K
Portfolio Weight0.15%
First reportedQ4 2025
Last changeHold
Updated2026-10-19

Last updated: 2026-10-19 · Source: SEC EDGAR Form 13F-HR

How PATHWAY WEALTH MANAGEMENT LLC's VRTX position evolved

PATHWAY WEALTH MANAGEMENT LLC first disclosed a stake in VRTX in Q4 2025 at 475 shares (US$215K). The position peaked in Q3 2026 at 425 shares, worth US$222K. Across 4 filings, PATHWAY WEALTH MANAGEMENT LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 425 shares valued at US$222K.

Quarter by quarter

QuarterSharesValueChange
Q4 2025 475 $215.35K New
Q1 2026 475 $212.11K Hold
Q2 2026 425 $211.11K Reduce
Q3 2026 425 $222.19K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VRTX and 13F data

VRTX (VERTEX PHARMACEUTICALS INC) is a Health Care company. 33 other funds we track also report a position in VRTX — the largest reported positions include Capital World Investors (US$12.97B), Capital World Investors (US$12.97B), Capital Research Global Investors (US$9.68B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VRTX

All VRTX fund holders →

FAQ

How long has PATHWAY WEALTH MANAGEMENT LLC held VRTX?

PATHWAY WEALTH MANAGEMENT LLC has disclosed VRTX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is PATHWAY WEALTH MANAGEMENT LLC's current position in VRTX?

As of Q3 2026, PATHWAY WEALTH MANAGEMENT LLC holds 425 shares of VRTX (VERTEX PHARMACEUTICALS INC), valued at $222.19K, representing 0.15% of its reported portfolio and ranking #30.

Has PATHWAY WEALTH MANAGEMENT LLC been buying or selling VRTX?

In the latest 13F filing (Q3 2026), PATHWAY WEALTH MANAGEMENT LLC held unchanged its position in VRTX. The position peaked in Q3 2026 at 425 shares.

Which other funds hold VRTX?

Other major institutional holders of VRTX include Capital World Investors, Capital World Investors, Capital Research Global Investors, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.